Showing 51 - 60 of 37,639
I examine physician agency in healthcare services in the context of the choice between brand-name and generic pharmaceuticals. I examine micro-panel data from Japan, where physicians can legally make profits by prescribing and dispensing drugs. The results indicate that physicians often fail to...
Persistent link: https://www.econbiz.de/10014180534
Throughout history the development of medical institution was followed by the extension of medical expertise boundaries. Progress in new medical biotechnologies and the manipulation of human biological material, in particular, raise the conceptual question of how to define the boundaries between...
Persistent link: https://www.econbiz.de/10014152213
On October 26, 2012, the University of Akron School of Law’s Center for Intellectual Property and Technology hosted its Sixth Annual IP Scholars Forum. In attendance were thirteen legal scholars with expertise and an interest in IP and public health who met to discuss problems and potential...
Persistent link: https://www.econbiz.de/10014158412
This paper studies the diffusion of biopharmaceuticals across European countries, focusing on anti-TNF drugs, which are used to treat autoimmune diseases (e.g., rheumatism, psoriasis). We use detailed sales information on the three brands Remicade, Enbrel and Humira for nine European countries...
Persistent link: https://www.econbiz.de/10014158749
This article offers a proposal for the regulation of stem cell products by the Food and Drug Administration (“FDA”) that corresponds to a specialized product liability scheme. It shows how product liability and administrative law can be successfully integrated to create a comprehensive legal...
Persistent link: https://www.econbiz.de/10014162099
Does the long-term economic stress of occupational decline cause health problems, or even death? This paper explores this question using Swedish administrative data, and a measure of occupational decline obtained from detailed US data on employment changes over almost 30 years. I investigate...
Persistent link: https://www.econbiz.de/10014250922
We study how market structure influenced the diffusion of new treatment technology (ICSI) among U.S. fertility clinics that performed in vitro fertilization (IVF). We find that competitive (i.e., non-monopoly) markets were more likely to have a clinic that offered ICSI than monopoly markets. Our...
Persistent link: https://www.econbiz.de/10014062129
A key feature of Sutton's theory is that industries evolve to distinct market configurations in terms of concentration depending upon whether the markets have a large size, whether the corresponding products are essentially homogeneous, whether they are differentiated by research and development...
Persistent link: https://www.econbiz.de/10014068645
We study the effect of hospital adoption of electronic medical records (EMRs) on health outcomes, particularly patient safety indicators (PSIs). We find evidence of a positive impact of EMRs on PSIs via decision support rather than care coordination. Consistent with this mechanism, we find an...
Persistent link: https://www.econbiz.de/10014037167
This amicus brief supports the FTC's position in the 2d Circuit appeal of 1-800 Contacts v. FTC. The brief was joined by 29 intellectual property, Internet law, and antitrust professors.The case involves 1-800 Contacts' settlement agreements with its online competitors in which they agreed not...
Persistent link: https://www.econbiz.de/10014104204